SAA1 gene variants and childhood obesity in China by unknown
Zhang et al. Lipids in Health and Disease 2013, 12:161
http://www.lipidworld.com/content/12/1/161RESEARCH Open AccessSAA1 gene variants and childhood obesity in
China
Xiao Zhang*, Qi-Zhu Tang, Ai-Ying Wan, Hai-Ju Zhang and Li WeiAbstract
Background: Obesity increases the risk for insulin resistance and metabolic syndrome in both adults and children.
SAA is a member of apolipoprotein and plays an important role in maintaining glucose and lipid homeostasis. The
purpose of this study was to assess SAA1 allelic variants with obesity in young school-age children.
Methods: A total of 520 consecutive children ages 5–15 years were recruited. Children were divided based on BMI
z score into Obese (OB; BMI z score ≥1.65; n = 253) and non-obese (NOB; n = 267). Four SNPs of the human SAA1
gene (rs12218, rs4638289, rs7131332 and rs11603089) were genotyped by use of polymerase chain reaction – re-
striction fragment length polymorphism (PCR-RFLP) method.
Results: Compared to NOB, circulating SAA levels were increased in OB, as were LDL-C, TG and TC concentration.
Obese children showed increased frequency of rs12218 and rs4638289 polymorphism compared to control children.
There were no differences between OB and NOB for the other 2 polymorphisms. Only the rs4638289 polymorphism
showed significant contributions to higher SAA plasma levels.
Conclusions: SAA1 genetic polymorphism was associated with obesity in Chinese children.
Keywords: Genetic polymorphisms, Serum amyloid A, Obesity, ChildhoodChildhood obesity is a serious public health problem
that has reached epidemic proportions all over the world
[1,2]. In children, the presence of obesity has been asso-
ciated with increased levels of high sensitivity CRP
(hsCRP) [3], as well as other inflammatory mediators
[4-8], all of which promote the development of endothe-
lial and metabolic dysfunction [9-12]. Serum amyloid A
(SAA) is not only a sensitive acute phase proteins in
plasma, but also an apolipoprotein that can replace apo-
lipoprotein A1 (apoA1) as the major apolipoprotein of
HDL-C, particularly during the acute phase response
[13]. Several studies suggested that SAA is associated
with obesity in adult [14]. And a meta-analysis found a
strong association between body mass index and SAA
levels [15]. Previous studies have demonstrated that SAA1
genetic polymorphism can change the plasma SAA levels
[16]. Therefore, the genetic polymorphisms in SAA1 may
be associated with obesity. Furthermore, several studies
have reported that rs12218 in SAA1 gene was associated* Correspondence: xiaozhan_g@163.com
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stated.with carotid atherosclerosis [17], HDL-C concentration
[18,19] and peripheral arterial disease [20]. However, the
relationship between SAA gene polymorphism and obesity
remains unknown.
In the present study, we aimed to investigate the rela-
tion between SAA1 genetic polymorphism and obesity
in Chinese children.Results and discussion
A total of 253 OB children and 267 age-, gender- and
ethnicity-matched NOB children were recruited during
January to July 2012. The demographic characteristics of
this cohort are shown in Table 1. As anticipated, OB
children had higher LDL-C, TC and TG levels compared
to NOB children (Table 1). OB children also had signifi-
cantly higher levels of SAA than NOB (Table 1).
The frequency of each of the SAA polymorphisms is
shown in Table 2 for OB and NOB children. Obese
children showed increased frequency of rs12218 and
rs4638289 polymorphism compared to control children.
There were no differences between OB and NOB for the
other 2 polymorphisms. Only the rs4638289 polymorphismLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise

















OB group 253 13.2 ± 0.9 21.1 ± 2.6 99.5 ± 12.6 61.0 ± 7.9 4.43 ± 0.47 0.61 ± 0.28 2.8 ± 0.7 0.87 ± 0.23 1.39 ± 0.49
NOB group 267 13.4 ± 1.0 17.1 ± 1.4 97.7 ± 12.7 61.4 ± 7.0 4.35 ± 0.48 0.52 ± 0.17 2.6 ± 0.6 0.88 ± 0.22 1.25 ± 0.36
P 0.102 <0.001 0.113 0.506 0.055 <0.001 0.001 0.734 <0.001
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levels (Table 3).
In the present study, we found that both rs12218 and
rs4638289 polymorphism in the SAA1 gene were associ-
ated with OB in Chinese Children. And the SAA plasma
levels are significantly higher in obese children. Further-
more, there was significant difference in SAA plasma
levels between each genotype of rs4638289 in SAA1 gene.
As described previously [18,20], SAA1 encodes one
important inflammation factor-SAA.. Recently, Xie et al.
reported that rs12218 polymorphism in SAA1 gene was
associated with IMT [17], HDL-C [18,19], Ankle-brachial
index (ABI) [20], and plasma uric acid levels [18] which
was related to cardiovascular disease in adults. And Zhang
et al. reported SAA1 gene polymorphism was associated
with cerebral infarction [21]. Xu et al. also reported SAA1
gene polymorphism was associated with lipid levels [19].
However, the relationship between SAA gene polymorph-
ism and obesity in Children remains unclear.
Inflammation is important in the pathogenesis of ath-
erosclerosis and obesity [15]. In 2000, Yamada et al. [22]
reported that the SAA1 genetic polymorphism influ-
ences the plasma concentration of SAA. In the present
study, we performed a case–control study to observe the
relationship between SAA1 genetic polymorphism and
obesity. We found rs12218 CC genotype and rs4638289
TT genotype are very common in the obesity patients
than that in the control subjects. Furthermore, we also
find the rs4638289 was associated with SAA level, but
the rs12218 was not found to be associated with SAATable 2 Distributions of SAA1 genotypes (OB = 253, NOB = 26
SNPs Allels (1/2) Groups
rs11603089 A/G NOB group 19
OB group 17
rs4638289 A/T NOB group 10
OB group 84
rs12218 C/T NOB group 15
OB group 12
rs7131332 A/G NOB group 67
OB group 65level in the present study. An elevated level of SAA
causes amyloidosis and is a risk factor for atherosclerosis
and its clinical complications, type 2 diabetes, as well as
various malignancies. The previous study [23] described
the first genome-wide association study on baseline SAA
concentrations. In a meta-analysis of four genome-wide
scans totalling 4,212 participants of European descent,
the authors identified two novel genetic susceptibility re-
gions on chromosomes 11 and 1 to be associated with
baseline SAA concentrations. The chromosome 11 re-
gion contains the serum amyloid A1 gene and the adja-
cent genes and explains a high percentage of the total
estimated heritability. In their study, the also found
rs463889 was associated with SAA concentration. Our
result was in line with their report. However, the mech-
anism which may link SAA1 genetic polymorphism to
obesity is still unknown. The change of plasma concen-
tration of SAA resulting from the genetic polymorphism
of SAA1 may be a possible mechanism which merits fur-
ther investigation.
In conclusion, SAA1 genetic polymorphism was asso-
ciated with obesity in Chinese children.
Subjects and methods
Subjects
The study was approved by the Wuhan University Human
Research Committee, and informed consent was obtained
from the legal caregiver of each participant. Consecutive
children between the ages of 5 to 15 years attending public
schools in Wuhan city were invited to participate in the7)
Genotypes (n, %) P value
1/1 1/2 2/2
2 (0.72) 70 (0.26) 5 (0.02) 0.302
2 (0.68) 71 (0.28) 10 (0.04)
7 (0.40) 134 (0.50) 26 (0.10) 0.001
(0.33) 114 (0.44) 55 (0.23)
2 (0.57) 102 (0.38) 13 (0.05) 0.014
9 (0.51) 94 (0.37) 30 (0.12)
(0.25) 160 (0.60) 40 (0.15) 0.897
(0.24) 147 (0.58) 41 (0.18)
Table 3 SAA concentration between each genotypes ( M + SD; ug/mL)
Group n rs11603089 rs4638289 rs12218 rs7131332





















































Note: compared to NOB group, *P < 0.05; Compared to AA genotype of rs4638289, △P < 0.05.
Zhang et al. Lipids in Health and Disease 2013, 12:161 Page 3 of 4
http://www.lipidworld.com/content/12/1/161study, after they underwent a school based health screen-
ing, which included height and weight measurements.
Based on such screening, children were identified when
their BMI z score was ≥ 1.65 (OB) and age-, gender-,
ethnicity-, and area-of residence-matched children with
BMI z scores <1.65 (NOB) were then identified and re-
cruited to serve as controls. Of note, all children were
otherwise healthy, and were representative of the demo-
graphic characteristics of the general population of the
city of Wuhan. Children were excluded if they had known
diabetes or pre-diabetes, any defined genetic abnormality
or underlying systemic disease including hypertension, or
if they were within a month from any acute infectious
process.
Genotyping
The selection and genotyping of SNPs was performed ac-
cording to Xie et al.’s protocol [20]. Briefly, we analyzed
four tagging SNPs (rs12218, rs4638289, rs7131332 and
rs11603089) in the present study. Genomic DNA was ex-
tracted from the peripheral blood leukocytes using a DNA
extraction Kit (Beijing Bioteke Co. Ltd). Genotyping was
confirmed by polymerase chain reaction (PCR) – restric-
tion fragment length polymorphism (RFLP) analysis. The
primer pair sequences, annealing temperatures and re-
striction enzymes for these four SNPs were described in
the previous study [18-20].
Anthropometry
To verify the school-health screening initial reports, chil-
dren were weighed in a calibrated scale to the nearest
0.1 kg and height (to 0.1 cm) was measured with a stadi-
ometer (Holtain, Crymych, UK). Body mass index (BMI)
was calculated and BMI z-score was computed using
CDC 2000 growth standards http://www.cdc.gov/growth-
charts and online software http://www.cdc.gov/epiinfo. A
BMI z score ≥ 1.65 was considered as fulfilling the criteria
for obesity.
Blood based assays
Blood samples were drawn by venipuncture in the morn-
ing after an overnight fast. Blood samples were immedi-
ately centrifuged and plasma was frozen at −80°C until
assay. Serum lipids including total cholesterol, high-density lipoprotein (HDL) cholesterol, calculated low-
density lipoprotein cholesterol (LDL), and triglycerides
(TG) were assessed using Flex Reagent Cartridges (Dade
Behring). Plasma SAA level was measured using enzyme-
linked immunosorbent assay (ELISA kit, Beijing Nothern
Biotechnology Institute, Beijing, China).
Statistical analyses
Analyses were carried out using SPSS version 17.0
(SPSS, Chicago, IL, USA). The Hardy–Weinberg equilib-
rium was assessed by chi-square analyses. The differ-
ences in the distribution of genotypes between OB and
NOB were analyzed using the chi-square test. General
linear model (GLM) analysis was performed to test for
associations between SNP genotypes and BMI after adjust-
ing for confounding variables. Normality was assessed by
plotting the residuals. Correction for multiple testing was
applied for the number of individual risk factors per geno-
type to achieve a probability value for significance to be
assumed before analysis was undertaken.
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